HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susac Syndrome

A rare disorder consisting of microangiopathy of brain, retina, and inner ear ARTERIOLES. It is characterized by the clinical triad of encephalopathy, BRANCH RETINAL ARTERY OCCLUSION and VERTIGO/hearing loss.
Also Known As:
Retinocochleocerebral Vasculopathy; Retinocochleocerebral Vasculopathies; Susacs Syndrome; Syndrome, Susac; Syndrome, Susac's; Vasculopathies, Retinocochleocerebral; Vasculopathy, Retinocochleocerebral; Susac's Syndrome
Networked: 148 relevant articles (9 outcomes, 7 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Cognitive Dysfunction
2. Brain Diseases (Brain Disorder)
3. Necrosis
4. Retinal Artery Occlusion
5. Hearing Loss (Hearing Impairment)

Experts

1. Dörr, Jan: 8 articles (12/2016 - 01/2012)
2. Paul, Friedemann: 7 articles (01/2019 - 01/2012)
3. Kleffner, Ilka: 7 articles (12/2016 - 01/2012)
4. Duning, Thomas: 5 articles (12/2016 - 06/2013)
5. Ringelstein, Marius: 5 articles (12/2016 - 01/2012)
6. Susac, John O: 5 articles (12/2011 - 04/2003)
7. Egan, Robert A: 4 articles (07/2022 - 04/2003)
8. Aktas, Orhan: 4 articles (12/2016 - 01/2012)
9. Postelmans, Laurence: 3 articles (03/2020 - 10/2008)
10. Gout, O: 3 articles (01/2019 - 09/2000)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Susac Syndrome:
1. Retinaldehyde (Retinal)IBA
2. Cyclophosphamide (Cytoxan)FDA LinkGeneric
3. Fluorescein (Funduscein)FDA LinkGeneric
4. Intravenous Immunoglobulins (IVIG)FDA Link
5. Infliximab (Remicade)FDA Link
6. CalciumIBA
7. Monoclonal AntibodiesIBA
8. Biomarkers (Surrogate Marker)IBA
9. Oxygen (Dioxygen)IBA
10. SteroidsIBA

Therapies and Procedures

1. Therapeutics
2. Length of Stay
3. Cochlear Implantation
4. Immunotherapy
5. Plasma Exchange